Literatur
-
1
Buchbinder R, Hill C.
Malignancy in patients with inflammatory myopathy.
Curr Rheumatol Rep.
2002;
4
415-426
-
2
Caproni M, Cardinali C, Parodi A. et al .
Amyopathic dermatomyositis: a review by an italien gruop of immunodermatology.
Arch Dermatol.
2002;
138
23-27
-
3
Chow W H, Gridley G, Mellemkjaer L, McLaughlin J K, Olsen J H, Fraumeni J F.
Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark.
Cancer Causes Control.
1995;
6
9-13
-
4
Kurzrock R, Cohen P R.
Cutaneous paraneoplastic syndromes in solid tumors.
Am J Med.
1995;
99
662-671
-
5
Lindelof B, Islam N, Eklund G, Arfors L.
Pemphigoid and cancer.
Arch Dermatol.
1990;
126
66-68
-
6
Nousari H C, Anhalt G J.
Pemphigus and bullous pemphigoid.
Lancet.
1999;
354
667-672
-
7
Sabir S, James W D, Schuchter L M.
Cutaneous manifestations of cancer.
Curr Opin Oncol.
1999;
11
139-144
-
8
Uehlinger E.
Paraneoplastische Syndrome.
Z Allgemeinmed.
1975;
51
122-127
-
9
Vielhauer V, Herzinger T, Korting H C.
The sign of Leser-Trelat: a paraneoplastic cutaneous syndrome that facilitates early diagnosis of occult cancer.
Eur J Med Res.
2000;
5
512-516
-
10
Wolff H.
Kutane Paraneoplasien.
Hautarzt.
2001;
52
159-172
-
11
Wuthrich B.
Paraneoplastische Dermatosen.
Ther Umsch.
1995;
52
282-287
1 Der Beitrag „Obligate Neoplasien der Haut” ist im vorhergehenden Heft (Nr. 42) erschienen.
Priv.-Doz. Dr. med. Andreas Blum
Univ.-Hautklinik Tübingen
Liebermeisterstraße 25
72076 Tübingen
Phone: 07071/2984555
Fax: 07071/294561
Email: a.blum@derma.de
